1Ghali P, Lindor KD. Hepatotoxicity of drugs used for treatment of obesity and its comorbidities. Semin Liver Dis , 2004,24: 389-397.
2Lee WM. Drug-induced hepatotoxicity. N Engl J Med, 1995,333: 1118-1127.
3Haddock CK, Poston WSC, Dill PL, et al. Phannacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials.Int J Obes Relat Metab Discord ,2002, 26:262-273.
4Dhawan M, Agrawal R, Ravi J, et al. Rosiglitazone-induced granulomatous hepatitis. J Clin Gastroenterol, 2002,34: 582-584.
5Lafuente NG. Calcium channel blockers and hepatotoxicity. Am J Gastroenterol, 2000, 95:2145.
